This inventor holds 2 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: S Michelle Deford: Innovator in Neuronal Disorder Treatments
Introduction
S Michelle Deford is a prominent inventor based in Richmond, VA (US). He has made significant contributions to the field of medicine, particularly in the treatment of neuronal disorders and traumatic brain injuries. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Deford's latest patents include a method for treating epilepsy and a method for treating traumatic brain injury. The first patent describes a method for the treatment of neuronal disorders and traumatic brain injury, which involves the timely administration of an effective amount of nefiracetam to a subject in need. The second patent also focuses on treating neuronal disorders and traumatic brain injury, emphasizing the importance of timely intervention with nefiracetam.
Career Highlights
Throughout his career, S Michelle Deford has been associated with Daiichi Pharmaceutical Co., Ltd., where he has been able to apply his innovative ideas in a practical setting. His work has garnered attention in the medical community, showcasing his dedication to improving treatment options for patients suffering from serious neurological conditions.
Collaborations
Deford has collaborated with notable colleagues such as Robert Hamm and Tadashi Shiotani. These partnerships have likely contributed to the development and refinement of his innovative methods.
Conclusion
S Michelle Deford's contributions to the treatment of neuronal disorders and traumatic brain injuries highlight his role as a key innovator in the medical field. His patents reflect a commitment to advancing healthcare solutions, and his collaborations further enhance the impact of his work.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile